M. C. Sádaba

发表

IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand

J. Lavandera, I. Castilla-Cortázar, J. Puche, 2013, Journal of Translational Medicine.

Serum levels of IgM to phosphatidylcholine predict the response of multiple sclerosis patients to natalizumab or IFN-β

E. Urcelay, F. Quintana, R. Arroyo, 2022, Scientific Reports.

Axonal and oligodendrocyte-localized IgM and IgG deposits in MS lesions

M. Esiri, M. García-Villanueva, J. Álvarez-cermeño, 2012, Journal of Neuroimmunology.

Mechanisms Underlying Testicular Damage and Dysfunction in Mice With Partial IGF-1 Deficiency and the Effectiveness of IGF-1 Replacement Therapy.

I. Castilla-Cortázar, J. Puche, L. Guerra-Menéndez, 2015, Urology.

Serum antibodies to phosphatidylcholine in MS

H. Weiner, R. Bakshi, P. Kivisäkk, 2020, Neurology: Neuroimmunology & Neuroinflammation.

Insulin-like growth factor 1 (IGF-1) therapy: Mitochondrial dysfunction and diseases.

I. Castilla-Cortázar, J. Puche, I. Martín-Estal, 2016, Biochimica et biophysica acta.

The single IGF-1 partial deficiency is responsible for mitochondrial dysfunction and is restored by IGF-1 replacement therapy.

I. Castilla-Cortázar, Ú. Muñoz, I. Martín-Estal, 2017, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand

J. Lavandera, I. Castilla-Cortázar, J. Puche, 2013, Journal of Translational Medicine.

Partial IGF-1 deficiency induces brain oxidative damage and edema, which are ameliorated by replacement therapy.

I. Castilla-Cortázar, J. Puche, Ú. Muñoz, 2016, BioFactors.

CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis

J. Gómez-Rial, J. Álvarez-cermeño, B. Casanova, 2009, Journal of Neuroimmunology.

Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS.

J. Masjuán, J. Álvarez-cermeño, N. Villarrubia, 2005, The Journal of clinical investigation.

Early differential diagnosis of multiple sclerosis using a new oligoclonal band test.

J. Masjuán, J. Álvarez-cermeño, L. Villar, 2005, Archives of neurology.

Immunological mechanisms that associate with oligoclonal IgM band synthesis in multiple sclerosis.

E. G. de la Concha, E. Urcelay, J. Álvarez-cermeño, 2010, Clinical immunology.

Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis

J. Masjuán, J. Álvarez-cermeño, E. Roldán, 2003, Annals of neurology.

High prevalence of intrathecal IgA synthesis in multiple sclerosis patients

E. Urcelay, R. Arroyo, R. Álvarez-Lafuente, 2021, Scientific reports.

Main Role of Antibodies in Demyelination and Axonal Damage in Multiple Sclerosis

M. Esiri, J. Tzartos, Ú. Muñoz, 2021, Cellular and Molecular Neurobiology.

Accuracy of CSF and MRI criteria for dissemination in space in the diagnosis of multiple sclerosis

J. Gómez-Rial, J. Álvarez-cermeño, L. Villar, 2008, Journal of the Neurological Sciences.

Deficiency in the production of antibodies to lipids correlates with increased lipid metabolism in severe COVID-19 patients

I. Martín-Antoniano, J. Castellano, A. Gradillas, 2023, Frontiers in Immunology.

Learning and assessment strategies to develop specific and transversal competencies for a humanized medical education

Antonio S. Tutor, J. G. Yague, I. Sánchez-Vera, 2023, Frontiers in Physiology.

IgM to phosphatidylcholine in multiple sclerosis patients: from the diagnosis to the treatment

Ú. Muñoz, I. Sánchez-Vera, E. Escudero, 2023, Therapeutic advances in neurological disorders.

Insulin-like growth factor 1 (IGF-1) therapy: Mitochondrial dysfunction and diseases.

I. Castilla-Cortázar, J. Puche, I. Martín-Estal, 2016, Biochimica et biophysica acta.